MedTrace Logo

Iowa Cochlear Implant Clinical Research Center Study of SSD Using Med-El Cochlear Implants

NCT03929809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2021-09-29

No results posted yet for this study

Summary

The purpose of this study is to understand the speech perception in noise and in quiet and localization benefits in a laboratory setting in listeners that receive a cochlear implant in an ear with severe to profound hearing loss and have normal, or near-normal hearing in the opposite ear. We will also evaluate the functional benefit of restoring hearing to the impaired ear via questionnaires that subjects will be answering while listening in their natural environment.

Conditions

  • Hearing Loss, Unilateral
  • Hearing Loss, Profound

Interventions

DEVICE

Cochlear Implant

adults with unilateral hearing loss who wish to regain bilateral hearing will be implanted with a cochlear implant on their deafened ear.

Sponsors & Collaborators

  • University of Iowa

    lead OTHER

Principal Investigators

  • Camille Dunn, PhD · University of Iowa

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-20
Primary Completion
2021-08-18
Completion
2021-08-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03929809 on ClinicalTrials.gov